Ready-to-use tranexamic acid intravenous solution
First Claim
Patent Images
1. An aqueous pharmaceutical composition in the form of a solution for parenteral administration comprising:
- tranexamic acid or a pharmaceutically acceptable salt thereof; and
a tonicity agent, wherein the composition requires no dilution before administration and has a pH from 6.0 to 8.0.
2 Assignments
0 Petitions
Accused Products
Abstract
Ready-to-use, stable aqueous intravenous tranexamic acid compositions are provided.
20 Citations
24 Claims
-
1. An aqueous pharmaceutical composition in the form of a solution for parenteral administration comprising:
- tranexamic acid or a pharmaceutically acceptable salt thereof; and
a tonicity agent, wherein the composition requires no dilution before administration and has a pH from 6.0 to 8.0. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, 22, 23, 24)
- tranexamic acid or a pharmaceutically acceptable salt thereof; and
-
15. A pharmaceutical composition for parenteral administration comprising a ready-to-use aqueous solution with a pH from about 6.0 to about 8.0 comprising:
- from 0.05 to about 15 mg/mL tranexamic acid or a pharmaceutically acceptable salt thereof;
a tonicity agent selected from (i) about 35 mg/mL to about 45 mg/mL mannitol or (ii) about 6.8-8.2 mg/mL sodium chloride; and
a pH adjuster in an amount to provide initial pH from about 6.0 to about 8.0. - View Dependent Claims (16, 17, 18, 19, 20)
- from 0.05 to about 15 mg/mL tranexamic acid or a pharmaceutically acceptable salt thereof;
Specification